DTIGN (Drug-Target Interaction Graph Network)

Drug discovery and biotech · by NYB

Proprietary AI model for bioactivity prediction using graph neural networks, outperforming nine leading methods by an average of 27.03% in bioactivity prediction correlation.

What it does

Proprietary AI model for bioactivity prediction using graph neural networks, outperforming nine leading methods by an average of 27.03% in bioactivity prediction correlation.

  • molecular discovery and compound identification
  • bioactivity prediction
  • natural compound screening
  • nutraceutical formulation development
  • therapeutic drug candidate development
Category
Drug discovery and biotech
Users
pharmaceutical researchers, nutraceutical brands, life science researchers
Public API
Not offered

Not yet disclosed: deployment options, platforms, languages and support channels.

Pricing

Pricing isn't published

NYB doesn't list prices publicly. Ask them for a quote.

Security and compliance

No security details published yet

NYB hasn't published certifications or security practices for DTIGN (Drug-Target Interaction Graph Network) that we could find. Ask their team for audit reports.

Reviews

No reviews yet

Reviews come from people who use DTIGN (Drug-Target Interaction Graph Network) at work. Share how your team uses it to help other buyers decide.

Alternatives

Is this your product?

Claim it to keep details accurate and submit evidence for the next ranking review.

Claim DTIGN (Drug-Target Interaction Graph Network)